A Phase 1/2a Study of BMS-986178 Administered Alone and in Combination With Nivolumab or Ipilimumab in Advanced Solid Tumors

Type of Cancer

Phase

Division (Location)

Study ID

NCT#

Brief Description
A Phase 1/2a Study of BMS-986178 Administered Alone and in Combination With Nivolumab or Ipilimumab in Advanced Solid Tumors

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.